« Previous
Next »
American Journal of Cardiology
Volume 99, Issue 6
, Pages 785-789
, 15 March 2007
Influence of Preoperative Lipid-Lowering Therapy on Postoperative Outcome in Patients Undergoing Coronary Artery Bypass Grafting
References
- Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Circulation. 2000;102:157–165
- . Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 1997;96:2137–2143
- . Beneficial effects of colestipol-niacin on coronary atherosclerosis (A 4-year follow-up). JAMA. 1990;264:3013–3017
- . The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Eng J Med. 1997;336:153–162
- . Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110(suppl):II-45–II-49
- . Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000;86:1128–1130
- . Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394–399
- . Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006;131:679–685
- . Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. J Am Coll Cardiol. 2005;45:336–342
- . Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesthes. 2004;18:605–609
- . Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997;95:1126–1131
- . Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation. 1999;99:3227–3233
- . HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol. 1998;32:2057–2064
- . Lovastatin therapy in hypercholesterolemia: effect on fibrinogen, hemorheologic parameters, platelet activity, and red blood cell morphology. J Clin Pharmacol. 1991;31:512–517
- . Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol. 2001;88:431–433
- . Effect of staatin therapy on C-reactive protein levels (The Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study). JAMA. 2001;286:64–70
- . Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221–2227
- . Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309–1317
- . Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005–2016
- . Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats. J Cardiovasc Pharm. 2003;41:649–656
- . HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J. 2001;15:1454–1456
- . Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. Med Sci Monit. 2003;9(suppl):BR155–BR159
- . Effects of statins on myocardial and coronary artery response to ischemia-reperfusion. Can J Phys Pharmacol. 2003;81:1064–1071
- . Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease (Results from the Lipid-Coronary Artery Disease (L-CAD) Study). Zeitschr Kardiol. 1999;88:582–590
- . Effect of concomitant or very early statin administration on in-hospital mortality and re-infarction rates in patients with acute myocardial infarction. Am J Cardiol. 2001;87:771–774
- . Effects of atorvastatin on early recurrent ischemc events in acute coronary syndrome: the MIRACL study. JAMA. 2001;285:1711–1718
- . Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty. Acta Cardiol. 2002;57:295–302
- . Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA study. Circulation. 2004;110:674–678
- . Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina. Eur J Cardiothorac Surg. 2005;27:1051–1056
- . Pre-operative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005;112(suppl I):I-286–I-292
This work was supported by a grant from Merck & Co., Inc., Whitehouse Station, New Jersey.
PII: S0002-9149(06)02367-8
doi: 10.1016/j.amjcard.2006.10.036
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 99, Issue 6
, Pages 785-789
, 15 March 2007
